Urovant Sciences

Urovant is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions.

Business Model:

Revenue: $104.6M

Employees: 51-200

Detailed Urovant Sciences Information

Geographic Data

Urovant Sciences headquarters map

Address: 5281 California Avenue

City: Irvine

State: CA

Zip: 92617

Country: US

Financial Info

Stage:

debt financing

Raised Last:

$100M

Raised Total:

$100M

Metrics

975,571Website Global Rank

35,822Website Monthly Traffic

Twitter Followers

Description

Urovant is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions.

Contact Phone:
+19492266029

Contact Email:

Urovant Sciences went public on the NASDAQ

Listed Exchange:
NASDAQ

Ticker Symbol:
UROV

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2019 Debt Financing 1 $100M Hercules Capital
Hercules Capital
Hercules Capital
Hercules Capital
12/2019 Debt $300M Sumitomo Dainippon Pharma
9/2018 IPO $140M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research